Five fusions (XPA-NCBP1, HARS2-ZMAT2, HSP90B1-DKFZp547P055, IL17RB-ACTR8, ANKRD23-ANKRD39) are identified to share with the fusions identified in prostate cancer but no fusions are shared with breast cancer, colorectal cancer, ovarian cancer, and lung cancer. Here, ZMAT2 is linked to prostate cancer.